| Monday, September 28th 2020

Registration open for TreatER webcast seminar – World’s 1st CDNF clinical trial: Aiming for a breakthrough in Parkinson’s

Twitter
| Wednesday, September 16th 2020

Recording on CDNF webinar available: CDNF Phase I-II Study Met Primary Endpoints of Safety and Tolerability at 12 months

Twitter
| Thursday, August 27th 2020

Renishaw announces completion of clinical trial extension study, using its innovative drug delivery system in the investigation of CDNF as a treatment for Parkinson’s disease

Twitter
| Monday, July 27th 2020

TreatER webcast seminar – World’s 1st CDNF clinical trial: Aiming for a breakthrough in Parkinson’s

Twitter
| Tuesday, April 14th 2020

Parkinsonsawarenessweek marked by an article on our clinical study with CDNF, aiming at breakthrough in Parkinsons

Twitter